Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Int J Drug Policy. 2014 Feb 28;25(5):845–852. doi: 10.1016/j.drugpo.2014.02.010

Table 2.

Bivariate drug and alcohol use associations with within-prison drug injection d sharing of injection equipment

Characteristic N Total n (%) Injected in prison n (%) Did not inject in prison n (%) p-value
Last incarceration drug-related 95 73 (76.8) 44 (81.5) 29 (70.7) 0.219
Met screening criteria for opioid dependence 95 80 (84.2) 49 (90.7) 31 (75.6) 0.045
Moderate to severe drug-use severity 95 88 (92.6) 51 (94.4) 37 (90.2) 0.438
Met screening criteria for any hazardous drinking 87 54 (62.1) 27 (54.0) 27 (73.0) 0.071
Met screening criteria for alcohol dependence 87 24 (27.6) 10 (20.0) 14 (37.8) 0.066
On OST at time of last incarceration 92 17 (18.5) 11 (21.6) 6 (14.6) 0.394
Opioid use 30 days prior to prison 92 70 (73.7) 48 (90.6) 22 (56.4) <0.001
Stimulant use 30 days before prison 85 45 (52.9) 26 (56.5) 19 (48.7) 0.473
Alcohol Use 30 days before prison 91 58 (63.7) 32 (65.3) 24 (60.0) 0.606
Poly-substance use 30 days before prison 86 57 (66.3) 35 (74.5) 22 (56.4) 0.078
Any drug injection during 30 days before prison 95 84 (88.4) 52 (96.3) 32 (78.0) 0.008
Mean injection days for those injecting (SD) 84 20.5 (±7.9) 20.1 (±7.1) 21.3 (±9.2) 0.350
Mean injections per day for those injecting (SD) 73 3.1 (±4.5) 3.3 (±4.7) 2.7 (±4.2) 0.213
Any high-risk injection 30 days before prison 95 75 (78.9) 46 (85.2) 29 (70.7) 0.087
Injection equipment sharing 30 days before prison 95 45 (47.4) 29 (53.7) 16 (39.0) 0.156
Common liquid drug container 30 days before prison 95 73 (76.8) 46 (85.2) 27 (65.9) 0.027
Injection-related morbidity 12 months before prison 94 64 (68.1) 44 (81.5) 20 (50.0) 0.001

Legend: SD=standard deviation; OST=opioid substitution therapy